Early palliative radiation versus observation for high-risk asymptomatic or minimally symptomatic bone metastases: study protocol for a randomized controlled trial.

MLA

Rosen, Daniel B., et al. “Early Palliative Radiation versus Observation for High-Risk Asymptomatic or Minimally Symptomatic Bone Metastases: Study Protocol for a Randomized Controlled Trial.” BMC Cancer, vol. 20, no. 1, Nov. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12885-020-07591-w.

APA

Rosen, D. B., Benjamin, C. D., Yang, J. C., Doyle, C., Zhang, Z., Barker, C. A., Vaynrub, M., Yang, T. J., & Gillespie, E. F. (2020). Early palliative radiation versus observation for high-risk asymptomatic or minimally symptomatic bone metastases: study protocol for a randomized controlled trial. BMC Cancer, 20(1), N.PAG. https://doi.org/10.1186/s12885-020-07591-w

Chicago

Rosen, Daniel B., Cory D. Benjamin, Joanna C. Yang, Connor Doyle, Zhigang Zhang, Chris A. Barker, Max Vaynrub, T. Jonathan Yang, and Erin F. Gillespie. 2020. “Early Palliative Radiation versus Observation for High-Risk Asymptomatic or Minimally Symptomatic Bone Metastases: Study Protocol for a Randomized Controlled Trial.” BMC Cancer 20 (1): N.PAG. doi:10.1186/s12885-020-07591-w.